Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose.

Autor: Kamath AV, Lu D, Gupta P, Jin D, Xiang H, Wong A, Leddy C, Crocker L, Schaefer G, Sliwkowski MX, Damico-Beyer LA
Zdroj: Cancer Chemotherapy & Pharmacology; Apr2012, Vol. 69 Issue 4, p1063-1069, 7p
Databáze: Complementary Index
Externí odkaz: